Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,770 | 0 | 0 | 0 | N/A |
| Other current assets | 114 | 0 | 0 | 0 | 0 |
| TOTAL | $4,650 | $1 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,552 | 85 | 0 | 0 | 0 |
| TOTAL | $1,552 | $85 | $N/A | $N/A | $N/A |
| Total Assets | $6,202 | $86 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 397 | 664 | 0 | 0 | 0 |
| Accrued Expenses | 1,416 | 2,202 | 0 | 0 | N/A |
| TOTAL | $2,009 | $5,681 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21 | 156 | 0 | 0 | 0 |
| TOTAL | $21 | $156 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,030 | $5,837 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,104 | 33,104 | N/A | N/A | N/A |
| Common Shares | 3 | 3 | 0 | 0 | N/A |
| Retained earnings | -26,022 | -24,495 | 0 | 0 | N/A |
| Other shareholders' equity | 0 | -75 | 0 | 0 | 0 |
| TOTAL | $4,172 | $-5,751 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $6,202 | $86 | $0 | $0 | $0 |